Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Van Campenhout, Jente, Buntinx, Yanthe, Xiong, Huan-Yu et al. · Biomolecules · 2025 · DOI
Quick Summary
This review examines how ME/CFS might involve two connected problems: the body's cells not producing enough energy, and the immune system not working properly. The authors suggest that when cells can't make enough energy, this might directly weaken the immune system, which could explain why patients experience severe fatigue and feel worse after physical activity. The review proposes that treatments targeting both energy production and immune function together might help patients more effectively than treating either problem alone.
Why It Matters
Understanding how energy metabolism and immune dysfunction are connected in ME/CFS is critical for developing better treatments. Most current approaches address only one system at a time; this review suggests targeting both simultaneously could be more effective. For patients, this integrated understanding may accelerate development of therapies that address the root causes of fatigue and post-exertional malaise rather than just symptoms.
Observed Findings
Mitochondrial dysfunction and impaired energy production are frequently reported in ME/CFS patients and correlate with symptom severity.
Immune senescence and exhaustion markers are detected in ME/CFS patient cohorts, similar to patterns seen in chronic viral infections.
Energy deficits in immune cells are known to impair their function in other disease contexts.
ME/CFS patients show altered immune profiles including abnormal cytokine levels and reduced immune cell proliferation.
Post-exertional malaise may be mechanistically linked to metabolic collapse following exertion.
Inferred Conclusions
Energy metabolism and immune dysfunction are interconnected in ME/CFS and may reinforce each other in a vicious cycle.
Therapeutic strategies that simultaneously target both mitochondrial function and immune regulation may be more effective than single-target approaches.
Understanding the metabolic-immune interplay provides a framework for developing novel, mechanism-based treatments for ME/CFS.
Remaining Questions
What is the causal direction and relative contribution of metabolic dysfunction to immune exhaustion versus immune dysfunction impairing metabolic recovery?
Which specific immune cells (T cells, B cells, NK cells) are most affected by energy deficits in ME/CFS, and how does this vary between patients?
What This Study Does Not Prove
This review does not prove that mitochondrial dysfunction directly causes immune exhaustion in ME/CFS patients—it identifies correlations and proposes theoretical mechanisms from existing literature. It is not a clinical trial, so it cannot demonstrate whether any proposed treatments actually work. The review reflects the state of current understanding, which remains incomplete due to limited mechanistic research in ME/CFS specifically.